The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss.
Source link
About The Author
Merck is establishing a separate cancer unit. The reorganization of its pharmaceutical business is aimed at bolstering product launches ahead of a key patent loss.